Key statistics
As of last trade, Harvard Bioscience Inc (HBI:DUS) traded at 0.44, 91.30% above the 52 week low of 0.23 set on May 08, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 0.44 |
|---|---|
| High | 0.44 |
| Low | 0.44 |
| Bid | 0.444 |
| Offer | 0.482 |
| Previous close | 0.456 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 44.72m |
| Free float | 40.90m |
| P/E (TTM) | -- |
| Market cap | 24.32m USD |
| EPS (TTM) | -1.22 USD |
Data delayed at least 15 minutes, as of Feb 12 2026 08:31 GMT.
More ▼
Announcements
- Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas
- Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth
- Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
- Harvard Bioscience Announces Third Quarter 2025 Financial Results
- Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET
- Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States
- Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors
- Harvard Bioscience Announces Second Quarter 2025 Financial Results
- Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET
- Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board
More ▼
